BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25303999)

  • 1. Conization as a marker of persistent cervical human papillomavirus (HPV) infection and risk of gastrointestinal cancer: a Danish 34-year nationwide cohort study.
    Kirkegård J; Farkas DK; Søgaard M; Schmidt SA; Ostenfeld EB; Cronin-Fenton D
    Cancer Causes Control; 2014 Dec; 25(12):1677-82. PubMed ID: 25303999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and the incidence of nonmelanoma and melanoma skin cancer using cervical conization as a surrogate marker: a nationwide population-based Danish cohort study.
    Schmidt SA; Hamilton-Dutoit SJ; Farkas DK; Steiniche T; Sørensen HT
    Ann Epidemiol; 2015 Apr; 25(4):293-296.e2. PubMed ID: 25560876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram-based prediction of cervical dysplasia persistence/recurrence.
    Bogani G; Tagliabue E; Ferla S; Martinelli F; Ditto A; Chiappa V; Leone Roberti Maggiore U; Taverna F; Lombardo C; Lorusso D; Raspagliesi F
    Eur J Cancer Prev; 2019 Sep; 28(5):435-440. PubMed ID: 30489353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
    Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
    Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer.
    Søgaard M; Farkas DK; Ording AG; Sørensen HT; P Cronin-Fenton D
    Br J Cancer; 2016 Aug; 115(5):588-91. PubMed ID: 27253173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human papillomavirus testing and cytology in follow-up after conization.
    Gosvig CF; Huusom LD; Deltour I; Andersen KK; Duun-Henriksen AK; Madsen EM; Petersen LK; Elving L; Schouenbourg L; Iftner A; Svare E; Iftner T; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):405-11. PubMed ID: 25645089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection and lymphoma incidence using cervical conization as a surrogate marker: a Danish nationwide cohort study.
    Intaraphet S; Farkas DK; Johannesdottir Schmidt SA; Cronin-Fenton D; Søgaard M
    Hematol Oncol; 2017 Jun; 35(2):172-176. PubMed ID: 28620926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.
    Sand FL; Kjaer SK; Frederiksen K; Dehlendorff C
    Int J Cancer; 2020 Aug; 147(3):641-647. PubMed ID: 31648368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological outcomes in HPV-screened elderly women in Denmark.
    St-Martin G; Viborg PH; Andersen ABT; Andersen B; Christensen J; Ejersbo D; Heje HN; Jochumsen KM; Johansen T; Larsen LG; Lynge E; Serizawa RR; Waldstrøm M
    PLoS One; 2021; 16(2):e0246902. PubMed ID: 33571319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable.
    Asciutto KC; Henic E; Darlin L; Forslund O; Borgfeldt C
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1251-1257. PubMed ID: 27513888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.
    Huang HJ; Tung HJ; Yang LY; Chao A; Tang YH; Chou HH; Chang WY; Wu RC; Huang CC; Lin CY; Liao MJ; Chen WC; Lin CT; Chen MY; Huang KG; Wang CJ; Chang TC; Lai CH
    Int J Cancer; 2021 Feb; 148(3):665-672. PubMed ID: 32781482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes.
    Bogani G; Sopracordevole F; Di Donato V; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Lagana' AS; Tinelli R; Signorelli M; De Vincenzo R; Zannoni GF; Ferrandina G; Lovati S; Petrillo M; Dessole S; Carlea A; Zullo F; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
    Gynecol Oncol; 2021 Apr; 161(1):173-178. PubMed ID: 33514481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer.
    González-Bosquet E; Fernandez S; Sabra S; Lailla JM
    Int J Gynaecol Obstet; 2017 Feb; 136(2):229-231. PubMed ID: 28099735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
    Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
    Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
    J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.